Annual EBIT
$8.67 B
+$212.28 M+2.51%
December 1, 2024
Summary
- As of February 7, 2025, SNY annual earnings before interest & taxes is $8.67 billion, with the most recent change of +$212.28 million (+2.51%) on December 1, 2024.
- During the last 3 years, SNY annual EBIT has fallen by -$1.02 billion (-10.50%).
- SNY annual EBIT is now -46.58% below its all-time high of $16.23 billion, reached on December 31, 2020.
Performance
SNY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$1.38 B
-$2.76 B-66.66%
December 1, 2024
Summary
- As of February 7, 2025, SNY quarterly earnings before interest & taxes is $1.38 billion, with the most recent change of -$2.76 billion (-66.66%) on December 1, 2024.
- Over the past year, SNY quarterly EBIT has dropped by -$2.76 billion (-66.66%).
- SNY quarterly EBIT is now -87.01% below its all-time high of $10.64 billion, reached on March 31, 2008.
Performance
SNY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$8.91 B
+$1.54 B+20.95%
December 1, 2024
Summary
- As of February 7, 2025, SNY TTM earnings before interest & taxes is $8.91 billion, with the most recent change of +$1.54 billion (+20.95%) on December 1, 2024.
- Over the past year, SNY TTM EBIT has increased by +$1.54 billion (+20.95%).
- SNY TTM EBIT is now -33.70% below its all-time high of $13.44 billion, reached on June 30, 2020.
Performance
SNY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SNY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | -66.7% | +20.9% |
| 3 y3 years | -10.5% | -48.9% | -10.0% |
| 5 y5 years | +140.7% | -48.9% | -10.0% |
SNY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | +2.5% | -68.2% | +955.2% | -31.0% | +29.6% |
| 5 y | 5-year | -46.6% | +140.7% | -84.5% | +931.7% | -33.7% | +146.8% |
| alltime | all time | -46.6% | +738.4% | -87.0% | +106.4% | -33.7% | +250.1% |
Sanofi EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.67 B(+2.5%) | $1.38 B(-66.7%) | $8.91 B(+21.0%) |
| Sep 2024 | - | $4.14 B(+152.0%) | $7.36 B(+7.2%) |
| Jun 2024 | - | $1.64 B(-5.4%) | $6.87 B(-6.3%) |
| Mar 2024 | - | $1.74 B(-1175.9%) | $7.33 B(-12.8%) |
| Dec 2023 | $8.46 B(-26.3%) | -$161.54 M(-104.4%) | $8.41 B(-34.9%) |
| Sep 2023 | - | $3.65 B(+73.5%) | $12.91 B(+7.1%) |
| Jun 2023 | - | $2.10 B(-25.3%) | $12.06 B(+4.8%) |
| Mar 2023 | - | $2.82 B(-35.1%) | $11.51 B(+1.0%) |
| Dec 2022 | $11.48 B(+18.5%) | $4.34 B(+55.2%) | $11.39 B(+29.5%) |
| Sep 2022 | - | $2.80 B(+80.3%) | $8.80 B(-8.2%) |
| Jun 2022 | - | $1.55 B(-42.6%) | $9.58 B(-3.2%) |
| Mar 2022 | - | $2.70 B(+54.5%) | $9.90 B(+2.1%) |
| Dec 2021 | $9.69 B(-40.3%) | $1.75 B(-51.1%) | $9.69 B(+22.0%) |
| Sep 2021 | - | $3.58 B(+91.3%) | $7.94 B(+81.9%) |
| Jun 2021 | - | $1.87 B(-25.1%) | $4.37 B(-61.7%) |
| Mar 2021 | - | $2.50 B(-72.0%) | $11.41 B(-15.1%) |
| Dec 2020 | $16.23 B(+350.7%) | - | - |
| Jun 2020 | - | $8.92 B(+290.5%) | $13.44 B(+217.4%) |
| Mar 2020 | - | $2.28 B(-1474.6%) | $4.23 B(+17.3%) |
| Dec 2019 | $3.60 B(-37.8%) | -$166.10 M(-106.9%) | $3.61 B(-1.5%) |
| Sep 2019 | - | $2.40 B(-938.8%) | $3.67 B(-17.6%) |
| Jun 2019 | - | -$286.47 M(-117.3%) | $4.45 B(-24.4%) |
| Mar 2019 | - | $1.66 B(-1599.6%) | $5.88 B(+1.1%) |
| Dec 2018 | $5.79 B(-14.1%) | -$110.67 M(-103.5%) | $5.82 B(-15.0%) |
| Sep 2018 | - | $3.18 B(+177.5%) | $6.84 B(+13.8%) |
| Jun 2018 | - | $1.15 B(-28.0%) | $6.01 B(-6.5%) |
| Mar 2018 | - | $1.59 B(+74.5%) | $6.43 B(-4.0%) |
| Dec 2017 | $6.74 B(-7.7%) | $913.81 M(-61.2%) | $6.70 B(-10.2%) |
| Sep 2017 | - | $2.36 B(+50.6%) | $7.46 B(-4.3%) |
| Jun 2017 | - | $1.56 B(-16.0%) | $7.79 B(-1.3%) |
| Mar 2017 | - | $1.86 B(+11.4%) | $7.89 B(+7.9%) |
| Dec 2016 | $7.30 B(+13.4%) | $1.67 B(-37.7%) | $7.31 B(+21.0%) |
| Sep 2016 | - | $2.69 B(+61.4%) | $6.04 B(+8.8%) |
| Jun 2016 | - | $1.67 B(+29.5%) | $5.55 B(-8.3%) |
| Mar 2016 | - | $1.29 B(+218.6%) | $6.05 B(-3.5%) |
| Dec 2015 | $6.44 B(-22.6%) | $403.73 M(-81.6%) | $6.27 B(-20.6%) |
| Sep 2015 | - | $2.20 B(+1.5%) | $7.90 B(-2.3%) |
| Jun 2015 | - | $2.16 B(+43.6%) | $8.09 B(+5.0%) |
| Mar 2015 | - | $1.51 B(-25.8%) | $7.70 B(-7.2%) |
| Dec 2014 | $8.32 B(+23.0%) | $2.03 B(-14.8%) | $8.30 B(+3.9%) |
| Sep 2014 | - | $2.38 B(+34.0%) | $7.99 B(+2.5%) |
| Jun 2014 | - | $1.78 B(-15.4%) | $7.79 B(+12.5%) |
| Mar 2014 | - | $2.10 B(+22.0%) | $6.93 B(+2.2%) |
| Dec 2013 | $6.76 B | $1.72 B(-21.2%) | $6.77 B(+21.1%) |
| Sep 2013 | - | $2.19 B(+138.7%) | $5.59 B(-9.5%) |
| Jun 2013 | - | $915.61 M(-53.1%) | $6.18 B(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $1.95 B(+260.7%) | $7.37 B(-11.9%) |
| Dec 2012 | $8.39 B(+0.2%) | $540.92 M(-80.5%) | $8.37 B(-10.4%) |
| Sep 2012 | - | $2.78 B(+32.1%) | $9.34 B(-5.7%) |
| Jun 2012 | - | $2.10 B(-28.8%) | $9.91 B(+5.0%) |
| Mar 2012 | - | $2.95 B(+94.6%) | $9.44 B(+12.7%) |
| Dec 2011 | $8.37 B(-4.9%) | $1.52 B(-54.7%) | $8.38 B(+4.4%) |
| Sep 2011 | - | $3.34 B(+105.6%) | $8.02 B(+16.7%) |
| Jun 2011 | - | $1.63 B(-13.9%) | $6.88 B(-16.3%) |
| Mar 2011 | - | $1.89 B(+62.4%) | $8.22 B(-10.3%) |
| Dec 2010 | $8.80 B(-1.2%) | $1.16 B(-47.1%) | $9.16 B(-7.8%) |
| Sep 2010 | - | $2.20 B(-25.9%) | $9.93 B(-3.1%) |
| Jun 2010 | - | $2.97 B(+4.8%) | $10.25 B(+13.7%) |
| Mar 2010 | - | $2.83 B(+46.3%) | $9.02 B(+1.8%) |
| Dec 2009 | $8.91 B(+35.0%) | $1.94 B(-23.1%) | $8.86 B(+182.7%) |
| Sep 2009 | - | $2.52 B(+45.2%) | $3.13 B(-30.9%) |
| Jun 2009 | - | $1.73 B(-35.1%) | $4.54 B(-14.1%) |
| Mar 2009 | - | $2.67 B(-170.5%) | $5.28 B(-60.1%) |
| Dec 2008 | $6.60 B(-21.1%) | -$3.79 B(-196.7%) | $13.24 B(-382.6%) |
| Sep 2008 | - | $3.92 B(+58.0%) | -$4.69 B(-578.0%) |
| Jun 2008 | - | $2.48 B(-76.7%) | $980.43 M(+31.6%) |
| Mar 2008 | - | $10.64 B(-149.0%) | $744.95 M(-215.7%) |
| Dec 2007 | $8.36 B(+10.9%) | -$21.72 B(-326.6%) | -$643.73 M(-316.8%) |
| Sep 2007 | - | $9.59 B(+327.0%) | $296.96 M(+249.9%) |
| Jun 2007 | - | $2.25 B(-75.7%) | $84.87 M(-110.8%) |
| Mar 2007 | - | $9.25 B(-144.5%) | -$783.24 M(-86.8%) |
| Dec 2006 | $7.54 B(+6.0%) | -$20.78 B(-321.7%) | -$5.94 B(-158.4%) |
| Sep 2006 | - | $9.37 B(+580.8%) | $10.16 B(+97.2%) |
| Jun 2006 | - | $1.38 B(-66.4%) | $5.15 B(-7.4%) |
| Mar 2006 | - | $4.09 B(-187.5%) | $5.56 B(-17.3%) |
| Dec 2005 | $7.12 B(+60.0%) | -$4.68 B(-207.3%) | $6.73 B(+95.2%) |
| Sep 2005 | - | $4.36 B(+144.1%) | $3.45 B(-38.5%) |
| Jun 2005 | - | $1.79 B(-66.0%) | $5.61 B(+18.3%) |
| Mar 2005 | - | $5.26 B(-166.0%) | $4.74 B(+109.6%) |
| Dec 2004 | $4.45 B(+28.0%) | -$7.96 B(-222.1%) | $2.26 B(-64.8%) |
| Sep 2004 | - | $6.52 B(+608.2%) | $6.42 B(+145.2%) |
| Jun 2004 | - | $921.24 M(-66.9%) | $2.62 B(+5.3%) |
| Mar 2004 | - | $2.78 B(-173.1%) | $2.49 B(+38.7%) |
| Dec 2003 | $3.48 B(+40.4%) | -$3.81 B(-239.9%) | $1.79 B(-32.1%) |
| Sep 2003 | - | $2.72 B(+244.4%) | $2.64 B(+50.0%) |
| Jun 2003 | - | $789.90 M(-62.2%) | $1.76 B(+14.5%) |
| Mar 2003 | - | $2.09 B(-170.6%) | $1.54 B(-379.6%) |
| Dec 2002 | $2.48 B(+31.2%) | -$2.96 B(-260.7%) | -$549.94 M(-122.9%) |
| Sep 2002 | - | $1.84 B(+224.9%) | $2.41 B(+324.9%) |
| Jun 2002 | - | $566.21 M | $566.21 M |
| Dec 2001 | $1.89 B(+29.5%) | - | - |
| Dec 2000 | $1.46 B(+40.9%) | - | - |
| Dec 1999 | $1.03 B | - | - |
FAQ
- What is Sanofi annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sanofi?
- What is Sanofi annual EBIT year-on-year change?
- What is Sanofi quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sanofi?
- What is Sanofi quarterly EBIT year-on-year change?
- What is Sanofi TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sanofi?
- What is Sanofi TTM EBIT year-on-year change?
What is Sanofi annual earnings before interest & taxes?
The current annual EBIT of SNY is $8.67 B
What is the all time high annual EBIT for Sanofi?
Sanofi all-time high annual earnings before interest & taxes is $16.23 B
What is Sanofi annual EBIT year-on-year change?
Over the past year, SNY annual earnings before interest & taxes has changed by +$212.28 M (+2.51%)
What is Sanofi quarterly earnings before interest & taxes?
The current quarterly EBIT of SNY is $1.38 B
What is the all time high quarterly EBIT for Sanofi?
Sanofi all-time high quarterly earnings before interest & taxes is $10.64 B
What is Sanofi quarterly EBIT year-on-year change?
Over the past year, SNY quarterly earnings before interest & taxes has changed by -$2.76 B (-66.66%)
What is Sanofi TTM earnings before interest & taxes?
The current TTM EBIT of SNY is $8.91 B
What is the all time high TTM EBIT for Sanofi?
Sanofi all-time high TTM earnings before interest & taxes is $13.44 B
What is Sanofi TTM EBIT year-on-year change?
Over the past year, SNY TTM earnings before interest & taxes has changed by +$1.54 B (+20.95%)